(PHILADELPHIA) –University of Pennsylvania researchers have received a five-year, $7.5 million grant from the National Cancer Institute (NCI) to create the Penn Center for Innovation in Personalized Breast Cancer Screening (PCIPS), dedicated to studying emerging methods of breast cancer detection. The NCI funding will allow the team, led by Perelman School of Medicine faculty Katrina Armstrong, MD, MSCE, chief of the division of Internal Medicine and associate director of Outcomes and Delivery in the Abramson Cancer Center, and Mitchell Schnall, MD, PhD, Matthew J. Wilson Professor of Radiology, to use clinical, genomic and imaging information to guide the use of novel, personalized breast cancer screening strategies that will reduce false positive rates to improve outcomes.” The research, which also involves researchers from medical oncology, psychiatry, and colleagues in the Annenberg School for Communication and the Wharton School, will be conducted through August 2016.
University of Pennsylvania researchers have received a five-year, $7.5 million grant from the National Cancer Institute (NCI) to create the Penn Center for Innovation in Personalized Breast Cancer Screening (PCIPS), dedicated to studying emerging methods of breast cancer detection. The NCI funding will allow the team, led by Perelman School of Medicine faculty Katrina Armstrong, MD, MSCE, chief of the division of Internal Medicine and associate director of Outcomes and Delivery in the Abramson Cancer Center, and Mitchell Schnall, MD, PhD, Matthew J. Wilson Professor of Radiology, to use clinical, genomic and imaging information to guide the use of novel, personalized breast cancer screening strategies that will reduce false positive rates to improve outcomes.” The research, which also involves researchers from medical oncology, psychiatry, and colleagues in the Annenberg School for Communication and the Wharton School, will be conducted through August 2016.
PCIPS research is three-fold. First, they will aim to improve breast cancer screening by creating a new “breast complexity index” to predict individual screening outcomes. Second, the team will also compare the effectiveness of new imaging technology, including digital breast tomosynthesis compared to conventional mammography. Third, they will create new strategies for communicating individual estimates of benefit and risk of alternative screening methods to better inform patients and health care providers.
Along with these three projects, the Center will study outcome data of a diverse group of 74,000 women who undergo breast cancer screening at six sites in Penn Medicine’s integrated health network. The center will use resources in breast imaging, primary care, communication, computer science, biostatistics, health services research, bioinformatics, medical oncology, cancer genetics and clinical leadership to advance the breast cancer screening process and encourage collaboration through NCI’s Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) network.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System (UPHS) and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $580 million awarded in the 2023 fiscal year. Home to a proud history of “firsts,” Penn Medicine teams have pioneered discoveries that have shaped modern medicine, including CAR T cell therapy for cancer and the Nobel Prize-winning mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System cares for patients in facilities and their homes stretching from the Susquehanna River in Pennsylvania to the New Jersey shore. UPHS facilities include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, chartered in 1751. Additional facilities and enterprises include Penn Medicine at Home, GSPP Rehabilitation, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.9 billion enterprise powered by nearly 49,000 talented faculty and staff.